[OpenAI President: AI is Becoming a New Variable in Conquering Diseases] According to Jinse Finance, on November 6th, Greg Brockman, co-founder and president of OpenAI, stated on the "No Priors" podcast that artificial intelligence has the potential to accelerate drug development and medical information matching, helping researchers and patients discover treatment clues related to specific diseases from massive amounts of medical literature. Brockman stated that some diseases do not lack treatment options entirely, but rather relevant research is scattered across numerous papers, making it difficult for patients and doctors to find them in a timely manner. If AI can identify a patient's condition and retrieve matching research results, it has the potential to expand the application scope of existing treatment methods. He believes that this capability already has the potential to have a practical impact in the short term. In addition to the medical field, Brockman also mentioned materials science and other areas, believing that AI can improve the efficiency of information analysis and scientific research, driving humanity to solve more complex problems.